Page last updated: 2024-11-03

propranolol and Tracheal Diseases

propranolol has been researched along with Tracheal Diseases in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Tracheal Diseases: Diseases involving the TRACHEA.

Research Excerpts

ExcerptRelevanceReference
"Propranolol has recently become the treatment of choice for management of subglottic and airway hemangiomas."8.95Efficacy and rebound rates in propranolol-treated subglottic hemangioma: A literature review. ( Chun, RH; Faria, J; Pawar, S; Schwartz, T; Siegel, D, 2017)
"Propranolol has recently become the treatment of choice for management of subglottic and airway hemangiomas."4.95Efficacy and rebound rates in propranolol-treated subglottic hemangioma: A literature review. ( Chun, RH; Faria, J; Pawar, S; Schwartz, T; Siegel, D, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwartz, T1
Faria, J1
Pawar, S1
Siegel, D1
Chun, RH1

Reviews

1 review available for propranolol and Tracheal Diseases

ArticleYear
Efficacy and rebound rates in propranolol-treated subglottic hemangioma: A literature review.
    The Laryngoscope, 2017, Volume: 127, Issue:11

    Topics: Hemangioma; Humans; Propranolol; Tracheal Diseases; Treatment Outcome; Vasodilator Agents

2017